Concentra Group Holdings Parent, Inc. (CON)
- Previous Close
22.82 - Open
22.90 - Bid 21.15 x 900
- Ask 23.00 x 900
- Day's Range
22.40 - 22.93 - 52 Week Range
18.89 - 24.81 - Volume
664,361 - Avg. Volume
789,343 - Market Cap (intraday)
2.912B - Beta (5Y Monthly) --
- PE Ratio (TTM)
16.58 - EPS (TTM)
1.37 - Earnings Date Jul 28, 2025 - Aug 12, 2025
- Forward Dividend & Yield 0.25 (1.10%)
- Ex-Dividend Date May 20, 2025
- 1y Target Est
28.00
Concentra Group Holdings Parent, Inc. provides occupational health services in the United States. The company offers occupational health services, including workers compensation, employer, and consumer health services; and employer-sponsored primary care services at workplace, including mobile health and episodic specialty testing services. It also operates Concentra Telemed, a telemedicine platform for the treatment of work-related injuries and illnesses; Concentra Pharmacy for distributing repackaged medications; and Concentra Medical Compliance Administration, a third-party administrator that helps to manage abuse testing programs for employers with regulated or non-regulated workforces. In addition, the company provides injury care, primary care, urgent care, preventive care, clinical testing, physical examinations and evaluations, drug and alcohol screenings, clinical testing, vaccinations and other preventive care, and a range of consultative services designed to protect employees from workplace hazards. The company was founded in 1979 and is based in Addison, Texas. Concentra Group Holdings Parent, Inc. was formerly a subsidiary of Select Medical Corporation.
www.concentra.com8,758
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: CON
View MorePerformance Overview: CON
Trailing total returns as of 5/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: CON
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: CON
View MoreValuation Measures
Market Cap
2.92B
Enterprise Value
5.01B
Trailing P/E
16.62
Forward P/E
16.53
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
1.51
Price/Book (mrq)
9.52
Enterprise Value/Revenue
2.59
Enterprise Value/EBITDA
13.53
Financial Highlights
Profitability and Income Statement
Profit Margin
8.09%
Return on Assets (ttm)
7.69%
Return on Equity (ttm)
20.93%
Revenue (ttm)
1.93B
Net Income Avi to Common (ttm)
155.83M
Diluted EPS (ttm)
1.37
Balance Sheet and Cash Flow
Total Cash (mrq)
52.46M
Total Debt/Equity (mrq)
645.86%
Levered Free Cash Flow (ttm)
144.3M